Center for Scientific Review; Amended Notice of Meeting, 29913 [2023-09865]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 89 / Tuesday, May 9, 2023 / Notices
Date: June 8–9, 2023.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Baskaran Thyagarajan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B,
Bethesda, MD 20892, (301) 867–5309,
thyagarajanb2@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 4, 2023.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09829 Filed 5–8–23; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel Small
Business: The Cancer Biotherapeutics
Development (CBD), June 12–13, 2023,
to July 17–18, 2023, National Institutes
of Health, 6701 Rockledge Drive
Bethesda, MD 20892, which was
published in the Federal Register on
May 01, 2023, 88 FR 26581 Doc 2023–
09094.
This meeting is being amended to
change the meeting date from June 12–
13, 2023, to July 17–18, 2023. The
meeting is closed to the public.
Dated: May 4, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09865 Filed 5–8–23; 8:45 am]
BILLING CODE 4140–01–P
ddrumheller on DSK120RN23PROD with NOTICES1
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health and Human
Development; Notice of Closed
Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
19:27 May 08, 2023
Jkt 259001
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Obstetrics and Maternal-Fetal
Biology Study Section.
Date: June 23, 2023.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Luis E. Dettin, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Eunice Kennedy Shriver National
Institute of Child Health and Human
Development, National Institutes of Health,
6710B Rockledge Drive, Room 2127D,
Bethesda, MD 20892, (301) 219–3400,
luis.dettin@nih.gov.
Name of Committee: National Institute of
Child Health and Human Development Initial
Review Group; Developmental Biology Study
Section.
Date: June 23, 2023.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, Eunice
Kennedy Shriver National Institute of Child
Health and Human Development, 6710B
Rockledge Drive, Room 2131B, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Jolanta Maria Topczewska,
Ph.D., Scientific Review Officer, Scientific
Review Branch, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, National Institutes of
Health, 6710B Rockledge Drive, Room 2131B,
Bethesda, MD 20892, (301) 451–0000,
jolanta.topczewska@nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
Dated: May 4, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2023–09859 Filed 5–8–23; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
29913
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention and Control Clinical Trials.
Date: June 1, 2023.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W254, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Susan Lynn Spence, Ph.D.,
Scientific Review Officer, Research
Technology and Contract Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Rockville, Maryland
20850, 240–620–0819, susan.spence@
nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI R01/
R34 Advancing Adolescent Tobacco
Cessation Intervention Review Meeting.
Date: June 2, 2023.
Time: 9:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W248, Rockville, Maryland 20850
(Telephone Conference Call).
Contact Person: Anita T. Tandle, Ph.D.,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W248,
Rockville, Maryland 20850, 240–276–5085,
tandlea@mail.nih.gov.
Name of Committee: National Cancer
Institute Initial Review Group; Institutional
Training and Education Study Section (F).
Date: June 21, 2023.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W234, Rockville, Maryland 20850
(Telephone Conference Call).
E:\FR\FM\09MYN1.SGM
09MYN1
]]>Agencies
[Federal Register Volume 88, Number 89 (Tuesday, May 9, 2023)]
[Notices]
[Page 29913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-09865]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the Center for
Scientific Review Special Emphasis Panel Small Business: The Cancer
Biotherapeutics Development (CBD), June 12-13, 2023, to July 17-18,
2023, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD
20892, which was published in the Federal Register on May 01, 2023, 88
FR 26581 Doc 2023-09094.
This meeting is being amended to change the meeting date from June
12-13, 2023, to July 17-18, 2023. The meeting is closed to the public.
Dated: May 4, 2023.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-09865 Filed 5-8-23; 8:45 am]
BILLING CODE 4140-01-P
